Identification of cellular retinoic acid binding protein 2 (CRABP2) as downstream target of nuclear factor I/X (NFIX): implications for skeletal dysplasia syndromes.

CRABP2 MSS RNA sequencing VCAM1 downstream genes proteomics retinoic acid

Journal

JBMR plus
ISSN: 2473-4039
Titre abrégé: JBMR Plus
Pays: England
ID NLM: 101707013

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 17 01 2024
revised: 04 04 2024
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: epublish

Résumé

Nuclear factor I/X (

Identifiants

DOI: 10.1093/jbmrpl/ziae060 PMID: 38827116 PMC: PMC11144382
pubmed: 38827116
doi: 10.1093/jbmrpl/ziae060
pii: ziae060
pmc: PMC11144382
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ziae060

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Auteurs

Kreepa G Kooblall (KG)

Academic Endocrine Unit, Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, United Kingdom.
ORCID: 0000-0001-9547-2067

Mark Stevenson (M)

Academic Endocrine Unit, Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, United Kingdom.

Raphael Heilig (R)

Target Discovery Unit, University of Oxford, Oxford OX3 7FZ, United Kingdom.

Michelle Stewart (M)

MRC Harwell, Mary Lyon Centre, Harwell Science and Innovation Campus, Oxfordshire OX11 0RD, United Kingdom.

Benjamin Wright (B)

Oxford Genomics Centre, The Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom.

Helen Lockstone (H)

Oxford Genomics Centre, The Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom.

David Buck (D)

Oxford Genomics Centre, The Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom.

Roman Fischer (R)

Target Discovery Unit, University of Oxford, Oxford OX3 7FZ, United Kingdom.

Sara Wells (S)

MRC Harwell, Mary Lyon Centre, Harwell Science and Innovation Campus, Oxfordshire OX11 0RD, United Kingdom.

Kate E Lines (KE)

Academic Endocrine Unit, Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, United Kingdom.

Lydia Teboul (L)

MRC Harwell, Mary Lyon Centre, Harwell Science and Innovation Campus, Oxfordshire OX11 0RD, United Kingdom.

Raoul C Hennekam (RC)

Department of Pediatrics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ Amsterdam, The Netherlands.

Rajesh V Thakker (RV)

Academic Endocrine Unit, Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, United Kingdom.

Classifications MeSH